HOPMAN MARK (Chief Commercial Officer) sold 1.4% of their position (775.00 shares) of BETA BIONICS, INC. on the open market
Open‑market sale worth $13.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/16/2026ACC: 0002048497-26-000021
Officer· Chief Commercial Officer
Since Mar 2026
-775.00
Net shares
Net seller
$13.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
775.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−775.00
Price / share
$17.35
Trade value
$13.45K
% of position
1.4%
10/14/2026
56.11K→55.33K
Total
Net shares
−775.00
Net value
-$13.45K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/14/2026 | S · Sale | −775.00 | $17.35 | $13.45K | 1.4% | 56.11K | 55.33K |
| Total | −775.00 | -$13.45K | ||||||
Derivative Transactions0
No derivative transactions reported